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Unfortunately, some phase 3 clinical studies failed to confirm the efficacy of promising new therapies for neovascular ARMD (Fovista ® ), central geographic atrophy (Lampalizumab) or Leber hereditary optic neuropathy (GS010).
In terms of artificial intelligence, robotic surgery can already assist critical steps of vitreo-retinal surgery and medical devices equipped with special software can analyze images and make referral recommendations in diabetic retinopathy and ARMD.
The non-invasive imaging of the retina was revolutionized by the outstanding development of optical coherence tomography (OCT). Today, OCT technology is present in all retina centers, being an irreplaceable tool for diagnosis, treatment guidance and monitoring. Recently, improvement in acquisition speed rate and software has led to the appearance of OCT angiography. We can now analyze changes in retinal vasculature, at different layers, in a quick, non-invasive, and dye-free manner.
Vitreoretinal surgery continuously evolved regarding efficiency, safety, and instrument compatibility. The shift towards a smaller G (up to 27G) makes vitrectomy quicker and significantly less invasive for the patient. New vitrectomy instruments are more efficient due to the cutting rate of up to 10000 cuts per minute via dual pneumatic drive technology. Due to ultra-high cutting speed capabilities and novel probe geometry, the surgeon can approach the retina much safer and use the probe for different purposes during surgery. Articulated Illuminated Laser Probes, especially adapted for small G surgery, help the surgeon to better view and treat the anterior periphery of the retina.
The NGENUITY 3D Visualization System, introduced by Alcon in 2016, enhances the surgeon's comfort, the intraoperative visualization of the retina and is an excellent teaching tool.
The Vitesse vitrectomy system, exclusively available on the Stellaris Elite system, might also represent a game changer in the future of vitrectomy technology. The ultrasound power (lower than the range for conventional phacoemulsification) is used to generate fluidic and mechanical cutting action for both fragmenting and removing vitreous. This promising new alternative to the currently guillotine-based technology is intended to be much safer, as only the liquefied vitreous near the edge of the port is removed.
During the last decade, retinology has achieved major improvements in imaging, medical, and surgical field with an outstanding dynamic. Thus, the science of the retina entered a new era, which is based on better knowledge and more efficient treatment options. There is no doubt that this progression will continue in the search for better and safer treatments.
